drugset / Trial / NCT03930069

Vasopressin Injection Versus Misoprostol During Hysteroscopic Myomectomy In Reducing Blood Loss And Operation Time.

NCT03930069

Phase 2/3 Completed 40 enrolled Zagazig University
RandomizedParallel-groupSingle-blindTreatment

Summary

A prospective randomized study designed to compare the efficacy of transcervical vasopressin injection versus vaginal misoprostol in reducing intra -operative blood loss during hysteroscopic mymectomy .

Timeline

Start
2016-05-02
Primary completion
2017-01-30
Completion
2017-03-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Other
Comparator Vasopressin Peptide 4 iu Other